#
5-Amino-1MQ
Elite Research5-Amino-1MQ is a small, synthetic molecule that acts as a selective inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT)
NNMT is involved in cellular metabolism and energy regulation, primarily in fat tissue, and its elevated activity is linked to conditions like obesity, type 2 diabetes, and certain cancers
By inhibiting NNMT, 5-Amino-1MQ promotes several potential health benefits:
Increases NAD+ Levels: Blocking NNMT boosts nicotinamide adenine dinucleotide (NAD+), a critical cofactor for cellular energy production, DNA repair, and mitochondrial function. This may enhance metabolism and support anti-aging processes
Enhances Fat Metabolism: 5-Amino-1MQ reduces fat accumulation by increasing basal metabolic rate (BMR) and promoting fat burning over storage. Studies in mice showed a 7% body weight reduction and 30% fat mass decrease over 10 days without changes in food intake
Improves Insulin Sensitivity: By upregulating GLUT4 transporter expression, it enhances glucose uptake, potentially aiding in blood sugar regulation and reducing insulin resistance
Supports Muscle Health: It activates muscle stem cells promoting muscle regeneration and potentially counteracting age-related muscle decline or disorders like Duchenne Muscular Dystrophy
Activates SIRT1: Increased NAD+ levels activate sirtuin-1 (SIRT1), known as the “longevity gene,” which may reduce risks of metabolic diseases, cardiovascular issues, and neurodegeneration
Potential Anti-Cancer Properties: Preliminary studies suggest 5-Amino-1MQ may inhibit cancer cell proliferation (e.g., in HeLa cervical cancer cells), though human data is lacking
Anti-Inflammatory Effects: By altering lipid profiles it may reduce inflammation and improve metabolic health
Research application
Copied from the handbook as research notes. and not instructions.
- Oral: 50 mg three times daily with meals for weight loss, with a one-month break every two months
- Injectable: 35-70mg once daily or split in two doses
Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes
From @BowTiedYukon